A randomized mixed-methods pilot feasibility trial of CBT group therapy with 4T-Integrated religious psychoeducation for religious obsessions and compulsions.

Psychother ResFeb 25, 2026 (epub)
Clinical ResearchPsychiatry

Taha Burak Toprak, M Hakan Turkcapar

✦ AI-curated · Sources linked

In 30 seconds

This randomized mixed-methods pilot feasibility trial evaluated whether the 4T religious psychoeducation model could be integrated into cognitive behavioural group therapy (CBGT) for adults with religious OCD. Twenty-three participants were assigned to standard CBGT or 4T-integrated CBGT, with symptom and cognitive assessments through 12-month follow-up and interviews about acceptability and cultural fit. Both approaches were feasible and well tolerated, and participants in each group showed within-group improvements. Exploratory trends suggested greater reductions in thought-action fusion likelihood and additional later cognitive shifts with 4T integration; the study was not designed to establish comparative efficacy.

Key findings

  • Both groups showed within-group improvements across symptom and cognitive measures.
  • Exploratory trends suggested greater reductions in thought-action fusion likelihood in the 4T-integrated group.
  • Participants viewed the 4T model as religiously congruent and reported clearer understanding of intrusive thoughts and greater motivation.

Why it matters

Religious concerns can shape how people understand intrusive thoughts and engage with OCD treatment. This pilot suggests that religiously grounded psychoeducation can be incorporated into group CBT in a way participants find acceptable and contextually relevant. The findings offer preliminary support for further evaluation, while the exploratory clinical results do not establish that the integrated approach is more effective than standard CBGT.

What to keep in mind

The pilot included only 23 participants, and its exploratory analyses do not establish comparative efficacy; the authors call for a larger definitive trial.

Source

Published in Psychother Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.